Press Releases

All Releases |  2014 |  2013 |  2012

Page: 1  

All Releases

Nov 26, 2014 Affymax, Inc. Announces a Special Cash Distribution And The Appointment Of a New Director And Chief Executive Officer
PDF 7.1 KB Add to Briefcase
Nov 26, 2014 Affymax Adopts Tax Benefit Preservation Plan to Protect Net Operating Loss Carryforwards
PDF 8.4 KB Add to Briefcase
Jun 6, 2013 Affymax Announces Update on Listing, Senior Leadership and Board Changes
PDF 6.8 KB Add to Briefcase
Apr 2, 2013 Affymax Reports Fourth Quarter and Year-End 2012 Financial Results
PDF 23.2 KB Add to Briefcase
Mar 18, 2013 Affymax Announces Reduction in Force to Align Resources Around Ongoing Product Investigation
PDF 7.5 KB Add to Briefcase
Feb 25, 2013 Affymax Announces Teleconference and Webcast
PDF 6.6 KB Add to Briefcase
Feb 23, 2013 Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
PDF 20.6 KB Add to Briefcase
Feb 6, 2013 Affymax to Present at the BIO CEO & Investor Conference
PDF 6.5 KB Add to Briefcase
Feb 1, 2013 Affymax Announces Updates to Senior Leadership Team
PDF 9.4 KB Add to Briefcase
Jan 23, 2013 New England Journal of Medicine Publishes Pivotal Trial Data for OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis
PDF 65.2 KB Add to Briefcase
Jan 7, 2013 Takeda and Affymax Announce Supply Agreement for OMONTYS® (Peginesatide) Injection with DSI Renal
PDF 17.2 KB Add to Briefcase
Jan 3, 2013 Affymax to Present at the J.P. Morgan Healthcare Conference
PDF 6.5 KB Add to Briefcase
Jan 3, 2013 Affymax and Takeda Announce Permanent J-Code for OMONTYS® (peginesatide) Injection is in Effect
PDF 17.8 KB Add to Briefcase
Showing 1-13 of 13 Page: 1  
Add to Briefcase = add release to Briefcase